From looking at the program, there were only 2 accepted oral papers for the Cancer of the Pancreas session - the rest are invited or panel discussions.
So,that's excellent.
Also I note a panel discussion on borderline resectable/non-resectable definitions, which would go a long way toward addressing the appropriate patient groups for oncosil treatment in future studies.
From looking at the program, there were only 2 accepted oral...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.050(4.42%) |
Mkt cap ! $20.33M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.15 | $1.08 | $45.62K | 40.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 718 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 2361 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |